Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Gossamer Bio Inc., 3 years.
Gossamer Bio Inc.
Director
Spyre Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Gossamer Bio Inc. June 25, 202580.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2025 | Gossamer Bio Inc. | Open-market purchase | +26,050 | $1.92 | $50,016 |
| Nov 15, 2023 | Gossamer Bio Inc. | Open-market purchase | +32,000 | $0.79 | $25,280 |
| May 4, 2023 | Organon & Co. | Option exercise | +4,984 | — | — |
| May 4, 2023 | Organon & Co. | Shares withheld for tax | −2,168 | $24.24 | $52,552 |
| May 1, 2023 | Organon & Co. | Option exercise | +1,899 | — | — |
| May 1, 2023 | Organon & Co. | Shares withheld for tax | −826 | $24.63 | $20,344 |
| Mar 31, 2023 | Organon & Co. | Option exercise | +5,964 | — | — |
| Mar 31, 2023 | Organon & Co. | Shares withheld for tax | −2,115 | $23.09 | $48,835 |
| Feb 28, 2023 | Organon & Co. | Option exercise | +7,976 | — | — |
| Feb 28, 2023 | Organon & Co. | Shares withheld for tax | −2,346 | $25.09 | $58,861 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.